welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients
study id #: NCT01604564
condition: Colitis, Ulcerative; Adenomatous Polyposis Coli; Reservoir, Ileoanal
status: active, not recruitingpurpose:
The purpose of this registry is to collect information about patients in which a pouch has been created to improve in the future the quality of the surgery of the pouch.
start date: May 2012
estimated completion: December 2019
last updated: October 16, 2018
size / enrollment: 200
study design: Observational Model: Cohort
Time Perspective: Prospective
To improve the quality of the surgery of the pouch created in CU and FAP patients, the following information will be collected: Patients Characteristics, Operative Data, Postoperative Outcome and Functional Postoperative Recovery.
- Evaluation of postoperatieve recovery [ Time Frame: 1 YEAR ] [ Designated as safety issue: No ]
STANDARD QUESTIONS AT 1, 3, 6 AND 12 MONTHS FU
Colitis Ulcerosa or Familial Adenomatous Polyposis Patients With IPAA
expertly curated content related to this topic
A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy VolunteersA pharmacokinetic study in healthy volun...
Adenoma Formation and Malignancy After Restorative Proctocolectomy with or without Mucosectomy in Patients with Fami...BACKGROUND : There is controversy concer...
Non Steroidal Anti-Inflammatory Drugs (NSAID) and Aspirin for Preventing Colorectal Adenomas and CarcinomasBACKGROUND : There is evidence from expe...
Therapeutic Approaches for Patients with Coexisting Familial Adenomatous Polyposis and Colorectal CancerColorectal cancer is a major cause of de...
Efficacy and Safety of Eflornithine (CPP-1X)/Sulindac Combination Therapy Versus Each as Monotherapy in Patients wit...BACKGROUND: Molecular studies suggest i...
Label-Free Global Serum Proteomic Profiling Reveals Novel Celecoxib-Modulated Proteins in Familial Adenomatous Polyp...Celecoxib, a selective inhibitor of cycl...
Despite Promise, Vitamin D and Calcium do not Reduce Colorectal Cancer RiskThe New England Journal of Medicine repo...